Immune cell constitution in bone marrow microenvironment predicts outcome in adult ALL

Show full item record



Permalink

http://hdl.handle.net/10138/303963

Citation

Hohtari , H , Bruck , O , Blom , S , Turkki , R , Sinisalo , M , Kovanen , P E , Kallioniemi , O , Pellinen , T , Porkka , K & Mustjoki , S 2019 , ' Immune cell constitution in bone marrow microenvironment predicts outcome in adult ALL ' , Leukemia , vol. 33 , no. 7 , pp. 1570-1582 . https://doi.org/10.1038/s41375-018-0360-1

Title: Immune cell constitution in bone marrow microenvironment predicts outcome in adult ALL
Author: Hohtari, Helena; Bruck, Oscar; Blom, Sami; Turkki, Riku; Sinisalo, Marjatta; Kovanen, Panu E.; Kallioniemi, Olli; Pellinen, Teijo; Porkka, Kimmo; Mustjoki, Satu
Contributor: University of Helsinki, HUS Comprehensive Cancer Center
University of Helsinki, Hematologian yksikkö
University of Helsinki, Institute for Molecular Medicine Finland
University of Helsinki, Institute for Molecular Medicine Finland
University of Helsinki, HUSLAB
University of Helsinki, Institute for Molecular Medicine Finland
University of Helsinki, Institute for Molecular Medicine Finland
University of Helsinki, HUS Comprehensive Cancer Center
University of Helsinki, HUS Comprehensive Cancer Center
Date: 2019-07
Language: eng
Number of pages: 13
Belongs to series: Leukemia
ISSN: 0887-6924
URI: http://hdl.handle.net/10138/303963
Abstract: As novel immunological treatments are gaining a foothold in the treatment of acute lymphoblastic leukemia (ALL), it is elemental to examine ALL immunobiology in more detail. We used multiplexed immunohistochemistry (mIHC) to study the immune contexture in adult precursor B cell ALL bone marrow (BM). In addition, we developed a multivariate risk prediction model that stratified a poor survival group based on clinical parameters and mIHC data. We analyzed BM biopsy samples of ALL patients (n = 52) and healthy controls (n = 14) using mIHC with 30 different immunophenotype markers and computerized image analysis. In ALL BM, the proportions of M1-like macrophages, granzyme B+CD57+CD8+ T cells, and CD27+ T cells were decreased, whereas the proportions of myeloid-derived suppressor cells and M2-like macrophages were increased. Also, the expression of checkpoint molecules PD1 and CTLA4 was elevated. In the multivariate model, age, platelet count, and the proportion of PD1+TIM3+ double-positive CD4+ T cells differentiated a poor survival group. These results were validated by flow cytometry in a separate cohort (n = 31). In conclusion, the immune cell contexture in ALL BM differs from healthy controls. CD4+PD1+TIM3+ T cells were independent predictors of poor outcome in our multivariate risk model, suggesting that PD1 might serve as an attractive immuno-oncological target in B-ALL.
Subject: ACUTE LYMPHOBLASTIC-LEUKEMIA
T-CELLS
IMATINIB MESYLATE
TUMOR
CHEMOTHERAPY
THERAPY
IMMUNOPHENOTYPE
IMMUNOSCORE
MECHANISMS
CONTEXTURE
3122 Cancers
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
s41375_018_0360_1.pdf 3.233Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record